These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7510913)

  • 21. [The significance of focal hypoechoic lesions in the peripheral zone of the prostate].
    Oyen R; Van Popel H; Van de Voorde W; Knapen P; Ameye F; Baert AL; Baert LV
    J Belge Radiol; 1995 Dec; 78(6):356-8. PubMed ID: 8576025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reference range for prostate-specific antigen levels after external beam radiation therapy for adenocarcinoma of the prostate.
    Geist RW
    Urology; 1995 Jun; 45(6):1016-21. PubMed ID: 7539558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.
    Zagars GK
    J Urol; 1994 Nov; 152(5 Pt 2):1786-91. PubMed ID: 7523725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of percentage of preradiation needle biopsies with adenocarcinoma and total radiation dose on the pathologic response of unfavorable prostate adenocarcinoma.
    Goldstein NS; Kestin LL; Vicini FA; Martinez AA
    Am J Clin Pathol; 2002 Jun; 117(6):927-34. PubMed ID: 12047145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: the relationship between nadir level and disease-free survival.
    Lee WR; Hanlon AL; Hanks GE
    J Urol; 1996 Aug; 156(2 Pt 1):450-3. PubMed ID: 8683700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of ultrasonography-guided prostatic biopsy of hypoechoic areas associated with systematic biopsies in patients with normal and high PSA levels].
    Scattoni V; Roscigno M; Raber M; Consonni P; Freschi M; Montorsi F; Pasta A; Colombo R; Nava L; Bua L; Rigatti P
    Arch Ital Urol Androl; 2002 Dec; 74(4):273-5. PubMed ID: 12508749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen levels.
    Dugan TC; Shipley WU; Young RH; Verhey LJ; Althausen AF; Heney NM; McManus PL; Abraham EH
    J Urol; 1991 Nov; 146(5):1313-6. PubMed ID: 1719244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome.
    Kupelian PA; Buchsbaum JC; Elshaikh MA; Reddy CA; Klein EA
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):629-34. PubMed ID: 14529766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between Doppler vascular density and PSA response to radiation therapy in patients with localized prostate carcinoma.
    Sehgal CM; Arger PH; Holzer AC; Krisch RE
    Acad Radiol; 2003 Apr; 10(4):366-72. PubMed ID: 12678175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific antigen (PSA) and radiotherapy in locally confined prostate cancer.
    Schaefer U; Micke O; Willich N
    Anticancer Res; 1999; 19(4A):2645-8. PubMed ID: 10470211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High-grade intraepithelial prostatic neoplasms: diagnosis and association with prostate cancer].
    Raviv G; Janssen T; Zlotta AR; Louis L; Descamps F; Verhest A; Schulman CC
    Acta Urol Belg; 1996 Mar; 64(1):11-5. PubMed ID: 8659330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
    Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
    Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extreme-risk prostate adenocarcinoma presenting with prostate-specific antigen (PSA)>40 ng/ml: prognostic significance of the preradiation PSA nadir.
    Alexander AS; Mydin A; Jones SO; Christie J; Lim JT; Truong PT; Ludgate CM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e713-9. PubMed ID: 21277102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.
    Wadasaki K; Kaneyasu Y; Kenjo M; Matsuura K; Murakami Y; Hashimoto Y; Ito K; Kiriu H; Ito A
    Int J Clin Oncol; 2007 Feb; 12(1):37-41. PubMed ID: 17380439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between peripheral hypoechoic nodules of the prostatic gland and prostate cancer].
    Herranz Amo F; Verdú Tartajo F; Díez Cordero JM; Hernández Fernández C; Rodríguez Fernández E; Lledó García E; Valer Algarabel J
    Actas Urol Esp; 1996 Sep; 20(8):725-32. PubMed ID: 9019947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome.
    Zietman AL; Coen JJ; Shipley WU; Willett CG; Efird JT
    J Urol; 1994 Mar; 151(3):640-5. PubMed ID: 7508522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Cancer J; 2001; 7(5):404-12. PubMed ID: 11693899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.
    Crook J; Robertson S; Collin G; Zaleski V; Esche B
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):31-7. PubMed ID: 7690016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N; Smolkin ME; Bissonette E; Theodorescu D
    Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.